Sweden· SE-20140205000017
Sivextro 200 mg Filmdragerad tablett
A medicinal product containing tedizolid phosphate, registered in Sweden by Merck Sharp & Dohme BV.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Tedizolid Phosphate
- Manufacturer
- Merck Sharp & Dohme BV
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer20140205000017
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Tedizolid phosphate in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumSivextro 200 mgMerck Sharp & Dohme
- CzechiaSIVEXTROMerck Sharp & Dohme B.V., Haarlem
- SpainSIVEXTRO 200 MG COMPRIMIDOS RECUBIERTOS CON PELICULAMerck Sharp & Dohme B.V.
- FinlandSivextroMerck Sharp & Dohme B.V.
- FranceSIVEXTRO 200 mg, comprimé pelliculéMERCK SHARP & DOHME (PAYS-BAS)
- IrelandSivextro 200 mg film-coated tabletsMerck Sharp & Dohme BV
- IcelandSivextroMerck Sharp & Dohme B.V.*
- NetherlandsSivextro 200 mg filmomhulde tablettenMerck Sharp & Dohme B.V.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Sivextro
- Liechtenstein · Sivextro
- Norway · Sivextro
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/9e776bd3-b392-4c40-af0e-80479b844424 GET /v1/drugs/9e776bd3-b392-4c40-af0e-80479b844424?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"EPAR",
"EMA"
],
"se_npl_id": "20140205000017",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20140205000017",
"product_doc_link": "https://www.ema.europa.eu/sv/documents/product-information/sivextro-epar-product-information_sv.pdf"
}See everything about tedizolid phosphate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.